BioSapien
biosapien.com
Actively hiring
Infusion & Drug Delivery Devices
Oncology Therapeutics
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$1.8M
1 round on record
Latest round
$1.8M
Seed · Nov 2021 · 4 yr ago
Team
11-50
employees, estimated range
Backers
1
Golden Gate Ventures
The money's age
Long since its last round
58 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 11, 2021
Raised a round Seed $1.8M · led by SOSV · Nasdaq
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Nov 2021 | $1.8M | SOSV lead, Hikma Ventures lead | Nasdaq |
Backed byfrom the funds' portfolios and accelerator catalogs
Golden Gate Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
BetaGlue Therapeutics — YntraDose®: a one-time, image-guided Yttrium-90 injection designed for durable local tumor control alongside…
RS & RS Scientific leads in cutting-edge cancer therapy research, developing innovative therapies for challenging cancer treatments. Their…
Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies…
Our Tumor Activated Permeability (TAP) Platform produces weakly-acidic derivatives of known oncology drugs that already work. It preserves…
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.
TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.
News
BIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - NOMINATED AS "BEST STARTUP" IN THE 2026 PRIX GALIEN USA AWARDS
BioSapien, the pioneering biotech company, is delighted to announce it has been nominated by The Galien Foundation - the premier global institution dedicated to honoring innovators in life sciences - in the "Best Startup" category, for the 20th Prix Galie
Read more
Report
BIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - NOMINATED AS "BEST STARTUP" IN THE 2026 PRIX GALIEN USA AWARDS
/PRNewswire/ -- BioSapien, the pioneering biotech company, is delighted to announce it has been nominated by The Galien Foundation - the premier global...
Read more
Report
BIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES
/PRNewswire/ -- BioSapien, the pioneering biotech company, announces two world-class US manufacturing partners, ahead of imminent Phase I clinical trials for...
Read more
Report
BIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES
Read more
Report
Abu Dhabi to trial new cancer treatment in drive to 'revolutionise' chemotherapy
US company BioSapien set to test 3D-printed mesh to combat colorectal cancer
Read more
Report
BioSapien advances to phase one clinical trials in Abu Dhabi following regulatory approvals
Received the required regulatory approvals for MediChip, its novel localised cancer drug delivery platform
Read more
Report
BioSapien wins Abu Dhabi regulatory approvals to begin Phase I cancer trials for its MediChip platform
The Department of Health, the Emirates Drug Establishment and an institutional review board have cleared the 3D-printed chemotherapy implant for first-in-human trials, with patient enrolment in colorectal cancer expected to begin within weeks.
Read more
Report
Dubai surgeons leave patient wearing a smile with 3D-printed jaw implant
Innovative prosthesis helps Jordanian patient regain speech and self-confidence after rare tumour
Read more
Report
How chemo pump to target tumours marks start of new era in UAE cancer care
Doctors hail 'breakthrough' device used to treat colorectal cancer patient in Abu Dhabi
Read more
Report
MENA Digest: BioSapien, Ebana, five others nab funding cheques
Funding activity in the Middle East and North Africa region this week was led by early-stage deals, with startups from the UAE, Saudi Arabia, and Egypt...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego
United States
Regional office
10-50 est. staff
11772 Sorrento Valley Road, San Diego, CA, 92121, US
Financials
Total raised
$1.8M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2021 | $1.8M | Details |